Nanotechnology in global medicine and human biosecurity: private interests, policy dilemmas, and the calibration of public health law.
This paper considers how best to approach dilemmas posed to global health and biosecurity policy by increasing advances in practical applications of nanotechnology. The type of nano-technology policy dilemmas discussed include: (1) expenditure of public funds, (2) public-funded research priorities, (3) public confidence in government and science and, finally, (4) public safety. The article examines the value in this context of a legal obligation that the development of relevant public health law be calibrated against less corporate-influenced norms issuing from bioethics and international human rights.
Faunce
Thomas A
TA
College of Law and Medical School at the Australian National University.
D001675:Bioethics; D014943:Global Health; D006291:Health Policy / Q000331:legislation & jurisprudence* / Q000639:trends; D006806:Human Rights; D006801:Humans; D036103:Nanotechnology / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends; D011634:Public Health / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends; D012637:Security Measures / Q000331:legislation & jurisprudence* / Q000639:trends